Occudo Quantitative Strategies’s Health Catalyst HCAT Stock Holding History

Occudo Quantitative Strategies’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,476	Closed	-$381K	–	1111
2023 Q2	$381K	Buy	+30,476	New	+$363K	0.04%	651
2023 Q1	–	Sell	-18,602	Closed	-$198K	–	1013
2022 Q4	$198K	Sell	18,602 -115,368	-86%	-$1.11M	0.02%	783
2022 Q3	$1.3M	Buy	133,970 +50,454	+60%	+$668K	0.1%	302
2022 Q2	$1.21M	Buy	83,516 +43,558	+109%	+$743K	0.1%	320
2022 Q1	$1.04M	Buy	39,958 +7,729	+24%	+$219K	0.09%	370
2021 Q4	$1.28M	Sell	32,229 -1,548	-5%	-$70.5K	0.11%	278
2021 Q3	$1.69M	Buy	33,777 +17,666	+110%	+$963K	0.2%	117
2021 Q2	$894K	Buy	16,111 +7,418	+85%	+$395K	0.14%	241
2021 Q1	$407K	Buy	+8,693	New	+$421K	0.09%	395

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's HCAT Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 30,476 shares — an estimated $381K sold.

Occudo Quantitative Strategies first reported a position in HCAT in Q1 2021 and held it in 9 quarters. The position peaked at $1.69M in Q3 2021. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

Occudo Quantitative Strategies reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
Occudo Quantitative Strategies sold 30,476 Health Catalyst shares in Q3 2023, an estimated $381K.
Occudo Quantitative Strategies first reported a position in Health Catalyst in Q1 2021 and held it in 9 quarters.
Occudo Quantitative Strategies's Health Catalyst position peaked at $1.69M in Q3 2021.
159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.